Share of adolescent girls vaccinated against human papillomavirus in Singapore
Singapore: Share of adolescent girls vaccinated against human papillomavirus was 68.0% in 2024. ◆ Volatile
Share of adolescent girls vaccinated against human papillomavirus in Singapore, 2013–2024
Source: WHO & UNICEF (2025) – processed by Our World in Data. Measured in %.
Analysis
Singapore recorded 68.0% for share of adolescent girls vaccinated against human papillomavirus in 2024.
Compared with earlier readings it is down 22.7% on the previous year and up 6,700.0% over ten years.
Over the whole period, share of adolescent girls vaccinated against human papillomavirus in Singapore peaked at 88.0% in 2023 and was at its lowest, 0.0%, in 2013.
That places Singapore 35th out of 74 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of adolescent girls vaccinated against human papillomavirus in Singapore, year by year
| Year | % | Change |
|---|---|---|
| 2013 | 0.0% | — |
| 2014 | 1.0% | — |
| 2015 | 1.0% | +0.0% |
| 2016 | 1.0% | +0.0% |
| 2017 | 1.0% | +0.0% |
| 2018 | 0.0% | -100.0% |
| 2019 | 0.0% | — |
| 2020 | 28.0% | — |
| 2021 | 58.0% | +107.1% |
| 2022 | 80.0% | +37.9% |
| 2023 | 88.0% | +10.0% |
| 2024 | 68.0% | -22.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.6% | 0.0% | 1.0% | 7 |
| 2020s | 64.4% | 28.0% | 88.0% | 5 |
Countries ranked near Singapore
- 33 Bolivia 69.0% compare
- 33 Czechia 69.0% compare
- 36 Argentina 67.0% compare
- 36 Cyprus 67.0% compare
- 38 Netherlands 65.0% compare
- 38 South Korea 65.0% compare
- 38 United States 65.0% compare
More health data for Singapore
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5225 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,924 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13 deaths (2100)
- Population ages 80 and above, female, per capita 0.017 units per person (2025)
- Population ages 80 and above, male, annual growth rate 3.83 % change on previous year (2025)
- Population ages 80 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 80 and above, male, per capita 0.0109 units per person (2025)
- Pertussis - number of reported cases, gaps filled 130 (2024)
- Pertussis - number of reported cases, per capita 0 units per person (2024)
Frequently asked questions
- What is share of adolescent girls vaccinated against human papillomavirus in Singapore?
- Share of adolescent girls vaccinated against human papillomavirus in Singapore was 68.0% in 2024, according to WHO & UNICEF (2025) – processed by Our World in Data.
- What is the highest share of adolescent girls vaccinated against human papillomavirus recorded in Singapore?
- The highest recorded value was 88.0% in 2023.
- What is the lowest share of adolescent girls vaccinated against human papillomavirus recorded in Singapore?
- The lowest recorded value was 0.0% in 2013.
- How does Singapore rank for share of adolescent girls vaccinated against human papillomavirus?
- Singapore ranks 35th out of 74 countries with data for 2024.
- Is share of adolescent girls vaccinated against human papillomavirus rising or falling in Singapore?
- Over the last ten years it is up 6,700.0%. The long-run trend across the full record is volatile.
- Where does this Singapore data come from?
- The figures come from WHO & UNICEF (2025) – processed by Our World in Data, published as part of Share of adolescent girls vaccinated against human papillomavirus. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.